This inventor holds 2 USPTO granted patents. Top assignees: The University of Texas System, Wisconsin Alumni Research Foundation. Active years: 2013-2015.
Company Filing History:
1 out of 5,633 
1 out of 4,237 
Years Active: 2013-2015
Title: Inventor Spotlight: Ariel Fernandez from Houston, TX
Introduction
Ariel Fernandez is a notable inventor based in Houston, Texas, who has made significant strides in the field of medical innovation. With two patents to her name, she is recognized for her cutting-edge work that addresses critical health challenges, particularly in the realm of heart failure.
Latest Patents
Ariel's latest patents showcase her innovative approach to medicine. The first patent, titled "Inhibition of MyBP-C binding to myosin as a treatment for heart failure," introduces methods for treating and slowing the onset of heart failure. This invention reveals that myosin binding to unphosphorylated Myosin Binding Protein C (MyBP-C) is a crucial factor in diminishing cardiac contractile force and frequency during heart failure. By developing peptide inhibitors of the MyBP-C/myosin interaction, Ariel's invention aims to enhance cardiac contractile force and frequency, benefiting not only patients with heart failure but also those at risk of developing the condition.
Her second patent focuses on "Methods and compositions related to wrapping of dehydrons." This application presents a novel technology that revolutionizes drug discovery and drug-based imaging/detection through a unique wrapping technology. This method leverages insights into the structure of soluble proteins, allowing scientists to use the dehydron pattern as a selectivity filter for designing small-molecule inhibitors. Such innovative rational drug design techniques aim to minimize side effects and optimize the inhibitory impact of drugs on the oncokinome.
Career Highlights
Throughout her career, Ariel has collaborated with renowned organizations, including the Wisconsin Alumni Research Foundation and the University of Texas System. Her contributions to these institutions highlight her commitment to advancing medical technology and research.
Collaborations
Ariel has worked alongside esteemed colleagues Richard L Moss and William G Bornmann, sharing her vision and expertise in developing new methodologies that enhance health outcomes. These collaborations reflect her dedication to fostering innovation through teamwork and collective knowledge.
Conclusion
Ariel Fernandez stands out as a pioneering inventor whose work addresses pressing medical challenges, particularly in cardiovascular health. Her patents not only demonstrate her innovative spirit but also promise to impact many lives positively. With a commitment to continued research and development, Ariel remains a significant figure in the field of medical innovation.